The mission of our ACGME-accredited fellowship is to provide an environment to develop the next generation of leaders in the fields of hematology and oncology. By utilizing resources and mentors ...

Please provide your email address to receive an email when new articles are posted on . The Oncology Core Education and Networking program provides over 20 hours of live virtual learning. Nearly 82% ...

The "Oncology Clinical Trials Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035" has been added to ...

Ann Arbor-based University of Michigan Health System announced the launch of the Translational Oncology Program to speed the translation of oncology research into clinical trials and treatment ...

Patient navigation programs are designed to promote access to timely cancer diagnosis and care by addressing barriers to cancer care, such as challenges with health literacy, language barriers ...

Cancer treatment is evolving rapidly, which presents both opportunities and challenges to hospitals seeking to maintain or expand their oncology services. Healthcare experts say cancer treatment, ...

Cardiovascular disease is the second leading cause of death among cancer survivors, second only to cancer itself. The same treatments that can save patients from cancer may also r ...

The Health Management Academy's executive forum recognized alongside ASCO, AACR, and other leading gatherings in ...

There is no one-size-fits-all approach for treating cancer. This is especially true for older adults, who typically face different challenges than younger adults during cancer care. At Penn Medicine ...

WellDoc continues to make moves. This morning the Baltimore-based company acquired home health consulting company Oncology Care Home Health Specialists for an undisclosed sum. The move will help ...

CRANFORD, N.J., Oct. 7, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), a specialty biopharmaceutical company focused on the development and ...

Global cancer incidence is projected to rise dramatically, with over 35 million new cases anticipated by 2050, disproportionately affecting low- and middle-income countries (LMICs) where up to 70% of ...